Loading provider…
Loading provider…
Radiation Oncology Physician in Youngstown, OH
NPI: 1255348454Primary Practice Location
ST ELIZABETH YOUNGSTOWN HOSPITAL
1044 Belmont Ave, Youngstown, OH
Primary Employer
Mercy Health Physicians Youngstown Specialty Care LLC
mercy.com
HQ Phone
Get M.D. Gilbert's Phone Numberphone_androidMobile
Get M.D. Gilbert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
MI State Medical License
2002 - 2027
OH State Medical License
2017 - 2026
PA State Medical License
2016 - 2021
NY State Medical License
1999 - 2002

American Board of Radiology
Radiation Oncology
College of Human Medicine - Grand Rapids
humanmedicine.msu.edu
Medical School
Until 1997
Memorial Sloan Kettering Cancer Center
Residency • Radiation Oncology
1988 - 2002
St Joseph Mercy Ann Arbor
Internship • Transitional Year
1997 - 1998
Authors: Massaccesi, Mariangela, Caravatta, Luciana, Cilla, Savino, Digesù, Cinzia, Deodato, Francesco, Macchia, Gabriella, Picardi, Vincenzo, Piscopo, Adele, Padula, Gilbert D A, Ferrandina, Gabriella, Scambia, Giovanni, Valentini, Vincenzo, Cellini, Numa, Piermattei, Angelo, Morganti, Alessio G
Journal: Tumori
Authors: Caravatta, Luciana, Sallustio, Giuseppina, Pacelli, Fabio, Padula, Gilbert D A, Deodato, Francesco, Macchia, Gabriella, Massaccesi, Mariangela, Picardi, Vincenzo, Cilla, Savino, Marinelli, Alfonso, Cellini, Numa, Valentini, Vincenzo, Morganti, Alessio G
Journal: Radiat Oncol
Publication Date: 2012-06-12
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Authors: Silvana Martino, Richard Gelber
Publication Date: 2014-06
Lead Sponsor: Academic and Community Cancer Research United
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Paclitaxel, DRUG: Eribulin Mesylate
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Clinical Observation, DRUG: Crizotinib
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, OTHER: Laboratory Biomarker Analysis, DRUG: Palbociclib